These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12367582)

  • 41. [Successful rituximab treatment in an elderly patient with recurrent thrombotic thrombocytopenic purpura].
    Matsubara E; Yamanouchi J; Hato T; Takeuchi K; Niiya T; Yasukawa M
    Rinsho Ketsueki; 2016 Jul; 57(7):869-72. PubMed ID: 27498731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura.
    George JN
    Am J Hematol; 2012 May; 87 Suppl 1():S88-91. PubMed ID: 22407740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ofatumumab for acute treatment and prophylaxis of a patient with multiple relapses of acquired thrombotic thrombocytopenic purpura.
    Al-Samkari H; Grace RF; Connors JM
    J Thromb Thrombolysis; 2018 Jul; 46(1):81-83. PubMed ID: 29564686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombotic thrombocytopenic purpura-what is new?
    Shah N; Sarode R
    J Clin Apher; 2013 Feb; 28(1):30-5. PubMed ID: 23420593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab.
    Caramazza D; Quintini G; Abbene I; Malato A; Saccullo G; Lo Coco L; Di Trapani R; Palazzolo R; Barone R; Mazzola G; Rizzo S; Ragonese P; Aridon P; Abbadessa V; Siragusa S
    Transfusion; 2010 Dec; 50(12):2753-60. PubMed ID: 20576013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short- and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura: four case reports.
    Iioka F; Shimomura D; Ishii T; Maesako Y; Ohgoe K; Nakamura F; Matsuo S; Ohno H
    Int J Hematol; 2012 Oct; 96(4):506-12. PubMed ID: 22878941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.
    Hagel S; Jantsch J; Budde U; Kalden JR; Eckardt KU; Veelken R
    Thromb Haemost; 2008 Jul; 100(1):151-3. PubMed ID: 18612551
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.
    Rubia J; Moscardó F; Gómez MJ; Guardia R; Rodríguez P; Sebrango A; Zamora C; Debén G; Goterris R; López R; Peña F; Pujol M; Vidaller A; Río-Garma JD; Sanz MA;
    Transfus Apher Sci; 2010 Dec; 43(3):299-303. PubMed ID: 20934383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.
    Zheng XL; Kaufman RM; Goodnough LT; Sadler JE
    Blood; 2004 Jun; 103(11):4043-9. PubMed ID: 14982878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange.
    Narayanan P; Jayaraman A; Rustagi RS; Mahadevan S; Parameswaran S
    Int J Hematol; 2012 Jul; 96(1):122-4. PubMed ID: 22552883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura.
    Foley SR; Webert K; Arnold DM; Rock GA; Clark WF; Barth D; Sutton DM;
    Kidney Int Suppl; 2009 Feb; (112):S55-8. PubMed ID: 19180138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease?
    Willis MS; Bandarenko N
    Semin Thromb Hemost; 2005 Dec; 31(6):700-8. PubMed ID: 16388421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab.
    Herbei L; Venugopal P
    Clin Adv Hematol Oncol; 2006 Mar; 4(3):215-7; discussion 217-8. PubMed ID: 16728931
    [No Abstract]   [Full Text] [Related]  

  • 55. Current insight into thrombotic thrombocytopenic purpura.
    Verbeke L; Delforge M; Dierickx D
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after Rituximab in children and young adults.
    Wieland I; Kentouche K; Jentzsch M; Lothschütz D; Graf N; Sykora KW
    Pediatr Blood Cancer; 2015 May; 62(5):823-9. PubMed ID: 25623397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP.
    Darabi K; Berg AH
    Am J Clin Pathol; 2006 Apr; 125(4):592-7. PubMed ID: 16627268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review.
    Harambat J; Lamireau D; Delmas Y; Ryman A; Llanas B; Brissaud O
    Pediatr Crit Care Med; 2011 Mar; 12(2):e90-3. PubMed ID: 20625343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura.
    Cataland SR; Wu HM
    Expert Opin Pharmacother; 2007 Mar; 8(4):437-44. PubMed ID: 17309338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of thrombotic thrombocytopenic purpura.
    van der Straaten M; Jamart S; Wens R; Gottignies P; Dratwa M; Devriendt J
    Intensive Care Med; 2005 Apr; 31(4):600. PubMed ID: 15703893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.